Recall measure seen to be hasty, less feasible

The Korea Food and Drug Administration (KFDA)’s sales ban was far from being feasible since it has not confirmed whether asbestos was really detected and on top of that, the KFDA measure was based on a supplement list of eight talc suppliers, according to pharmaceutical business sources.

Last week, 1,122 medicinal drugs produced by 120 companies were banned from sale.

The drug authoritie...